Source: Morgan Lewis

As healthcare organizations expand AI use beyond ambient dictation and revenue-cycle tasks to broader clinical and operational applications, the piece stresses that legal, regulatory, and data-governance complexity rises accordingly. Deployment decisions hinge on whether HIPAA applies, whether protected health information (PHI) is implicated, and whether lawful pathways such as treatment, payment, or healthcare operations permit the intended use; these determinations shape system architecture, vendor selection, and permissible data flows. Contracting, including business associate agreements (BAAs) and data-governance clauses, is presented as a primary compliance mechanism to allocate responsibilities, restrict data use, and clarify ownership of inputs and outputs.

The series previewed in the publication covers lifecycle and operational themes: FDA oversight of clinical decision support and other AI tools, evolving state and federal privacy regimes, algorithmic accountability including bias mitigation and auditability, procurement strategy, vendor diligence, reimbursement implications, cybersecurity risk, and integration with existing health IT. A recurring conclusion is that AI in healthcare requires ongoing governance—systems must be monitored, validated, and updated as data, use cases, and regulatory expectations evolve—and organizations are advised to pair disciplined planning with proactive compliance practices. Readers are invited to use the series as a starting point and to contact the firm’s healthcare and privacy lawyers for specific use-case guidance.